Cargando…
Small molecule stabilization of the KSR inactive state antagonizes oncogenic Ras signalling
Deregulation of the Ras–mitogen activated protein kinase (MAPK) pathway is an early event in many different cancers and a key driver of resistance to targeted therapies(1). Sustained signalling through this pathway is caused most often by mutations in K-Ras, which biochemically favours the stabiliza...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5161575/ https://www.ncbi.nlm.nih.gov/pubmed/27556948 http://dx.doi.org/10.1038/nature19327 |